Effects of chronic ketamine use on frontal and medial temporal cognition

Addictive Behaviors

Volumn 38, Issue 5, 2013, Pages 2128-2132

  Chan, Kahlen W S ^a   Lee, Tatia M C ^a,b   Siu, Andrew M H ^c   Wong, Debby P L ^d   Kam, Chi Ming ^a   Tsang, Sandra K M ^a   Chan, Chetwyn C H ^c  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

^b UNIVERSITY OF HONG KONG   (Hong Kong)

^c HONG KONG POLYTECHNIC UNIVERSITY   (Hong Kong)

^d Caritas Youth and Community Service   (Hong Kong)

Author keywords

Addiction; Cognition; Drug; Ketamine; Substance abuse

Indexed keywords

KETAMINE;

ADULT; ARTICLE; ATTENTION; CLINICAL ARTICLE; COGNITION; CONTROLLED STUDY; EXECUTIVE FUNCTION; FEMALE; FLUENCY DISORDER; HUMAN; LEARNING; LEARNING DISORDER; MALE; MEMORY; NEUROPSYCHOLOGICAL TEST; SELECTIVE ATTENTION; VISUAL MEMORY;

ATTENTION; CASE-CONTROL STUDIES; COGNITION DISORDERS; DOSE-RESPONSE RELATIONSHIP, DRUG; EXCITATORY AMINO ACID ANTAGONISTS; FEMALE; HUMANS; KETAMINE; LANGUAGE DISORDERS; MALE; MEMORY DISORDERS; NEUROPSYCHOLOGICAL TESTS; SUBSTANCE-RELATED DISORDERS; VERBAL LEARNING; YOUNG ADULT;

EID: 84874415899     PISSN: 03064603     EISSN: 18736327     Source Type: Journal    
DOI: 10.1016/j.addbeh.2013.01.014     Document Type: Article

References (52)

1. Barratt E.S. Impulsiveness and aggression. Violence and mental disorder 1994, 61-79. University of Chicago Press, Chicago, IL. J. Mohanan, H.J. Steadman (Eds.).
2. Beck A.T. Beck depression inventory 1987, Psychological Corporation, Texas.
3. Benton A.L., Hamsher K., Varney N.R., Spreen O. Contributions to neuropsychological assessment 1983, Oxford University Press, New York, NY.
4. Bernstein H.G., Becker A., Keilhoff G., Spilker C., Gorczyca W.A., Braunewell K.H., et al. Brain region-specific changes in the expression of calcium sensor proteins after repeated applications of ketamine to rats. Neuroscience Letters 2003, 339(2):95-98.
5. Breier A., Malhotra A.K., Pinals D.A., Weisenfeld N.I., Pickar D. Association of ketamine-induced psychosis with focal activation of the prefrontal cortex in healthy volunteers. The American Journal of Psychiatry 1997, 154(6):805-811.
6. Brown L., Sherbenou R.J., Johnsen S.K. Test of non-verbal intelligence: A language-free measure of cognitive ability 1997, Pro-ed, Texas. 3rd ed.
7. Central Registry of Drug Abuse Fifty-ninth report 2011, Hong Kong Narcotics Division, Hong Kong Government.
8. Cotman C.W., Monaghan D.T., Ganong A.H. Excitatory amino acid neurotransmission: NMDA receptors and Hebb-type synaptic plasticity. Annual Review of Neuroscience 1988, 11:61-80.
9. Curran H.V., Monaghan L. In and out of the K-hole: A comparison of the acute and residual effects of ketamine in frequent and infrequent ketamine users. Addiction 2001, 96(5):749-760.
10. Curran H.V., Morgan C. Cognitive, dissociative and psychotogenic effects of ketamine in recreational users on the night of drug use and 3days later. Addiction 2000, 95(4):575-590.
11. Deakin J.F.W., Lees J., Mckie S., Hallak J.E.C., Williams S.R., Dursun S.M. Glutamate and the neural basis of the subjective effects of ketamine. Archives of General Psychiatry 2008, 65(2):154-164.
12. Fama R., Sullivan E.V., Shear P.K., Cahn-Weiner D.A., Marsh L., Lim K.O., et al. Structural brain correlates of verbal and nonverbal fluency measures in Alzheimer's disease. Neuropsychology 2000, 14(1):29-40.
13. Fishbein D.H., Krupitsky E., Flannery B.A., Langevin D.J., Bobashev G., Verbitskaya E., et al. Neurocognitive characterizations of Russian heroin addicts without a significant history of other drug use. Drug and Alcohol Dependence 2007, 90(1):25-38.
14. Halpern J.H., Pope H.G., Sherwood A.R., Barry S., Hudson J.I., Yurgelun-Todd D. Residual neuropsychological effects of illicit 3,4-methylenedioxymethamphetamine (MDMA) in individuals with minimal exposure to other drugs. Drug and Alcohol Dependence 2004, 75(2):135-147.
15. Hetem L.A., Danion J.M., Diemunsch P., Brandt C. Effect of a subanesthetic dose of ketamine on memory and conscious awareness in healthy volunteers. Psychopharmacology 2000, 152(3):283-288.
16. 2O)-O-15 demonstrate ketamine actions in CNS dynamically. Neuropsychopharmacology 2001, 25(2):165-172.
17. Honey R.A., Honey G.D., O'Loughlin C., Sharar S.R., Kumaran D., Bullmore E.T., et al. Acute ketamine administration alters the brain responses to executive demands in a verbal working memory task: An FMRI study. Neuropsychopharmacology 2004, 29(6):1203-1214.
18. Honey R.A., Turner D.C., Honey G.D., Sharar S.R., Kumaran D., Pomarol-Clotet E., et al. Subdissociative dose ketamine produces a deficit in manipulation but not maintenance of the contents of working memory. Neuropsychopharmacology 2003, 28(11):2037-2044.
19. Jansen K.L. Ketamine-Can chronic use impair memory?. The International Journal of the Addictions 1990, 25(2):133-139.
20. Kakiuchi T., Nishiyama S., Sato K., Ohba H., Nakanishi S., Tsukada H. Effect of MK801 on dopamine parameters in the monkey brain. NeuroImage 2001, 16:110.
21. Kane M.J., Engle R.W. The role of prefrontal cortex in working-memory capacity, executive attention, and general fluid intelligence: An individual-differences perspective. Psychonomic Bulletin Review 2002, 9(4):637-671.
22. Kondo H., Osaka N., Osaka M. Cooperation of the anterior cingulate cortex and dorsolateral prefrontal cortex for attention shifting. NeuroImage 2004, 23(2):670-679.
23. Krystal J.H., Karper L.P., Seibyl J.P., Freeman G.K., Delaney R., Bremner J.D., et al. Subanesthetic effects of the noncompetitive NMDA antagonist, ketamine, in humans. Psychotomimetic, perceptual, cognitive, and neuroendocrine responses. Archives of General Psychiatry 1994, 51(3):199-214.
24. Lee T.M.C., Chan C.C.H. Stroop interference in Chinese and English. Journal of Clinical and Experimental Neuropsychology 2000, 22(4):465-471.
25. Lee T.M.C., Yuen K., Chan C.C.H. Normative data for neuropsychological measures of fluency, attention, and memory measures for Hong Kong Chinese. Journal of Clinical and Experimental Neuropsychology 2002, 24(5):615-632.
26. Lewis R.F. Digit Vigilance Test: Professional user's guide 1992, American Psychological Association, Washington, DC.
27. Lezak M.D. Neuropsychological assessment 1995, Oxford University Press, New York, NY.
28. Liao Y., Tang J., Corlett P.R., Wang X., Yang M., Chen H., et al. Reduced dorsal prefrontal gray matter after chronic ketamine use. Biological Psychiatry 2011, 69(1):42-48.
29. Mak Y.T., Lam W.P., Lu L., Wong Y.W., Yew D.T. The toxic effect of ketamine on SH-SY5Y neuroblastoma cell line and human neuron. Microscopy Research and Technique 2010, 73(3):195-201.
30. McCambridge J., Winstock A., Hunt N., Mitcheson L. 5-Year trends in use of hallucinogens and other adjunct drugs among UK dance drug users. European Addiction Research 2007, 13(1):57-64.
31. Morgan C.J., Curran H.V. Acute and chronic effects of ketamine upon human memory: A review. Psychopharmacology 2006, 188(4):408-424.
32. Morgan C.J., Mofeez A., Brandner B., Bromley L., Curran H.V. Acute effects of ketamine on memory systems and psychotic symptoms in healthy volunteers. Neuropsychopharmacology 2004, 29(1):208-218.
33. Morgan C.J., Monaghan L., Curran H.V. Beyond the K-hole: A 3-year longitudinal investigation of the cognitive and subjective effects of ketamine in recreational users who have substantially reduced their use of the drug. Addiction 2004, 99(11):1450-1461.
34. Morgan C.J., Muetzelfeldt L., Curran H.V. Ketamine use, cognition and psychological wellbeing: A comparison of frequent, infrequent and ex-users with polydrug and non-using controls. Addiction 2009, 104(1):77-87.
35. Morgan C.J., Muetzelfeldt L., Curran H.V. Consequences of chronic ketamine self-administration upon neurocognitive function and psychological wellbeing: A 1-year longitudinal study. Addiction 2010, 105(1):121-133.
36. Morris R.G., Anderson E., Lynch G.S., Baudry M. Selective impairment of learning and blockade of long-term potentiation by an N-methyl-d-aspartate receptor antagonist, AP5. Nature 1986, 319(6056):774-776.
37. Narendran R., Frankle W.G., Keefe R., Gil R., Martinez D., Slifstein M., et al. Altered prefrontal dopaminergic function in chronic recreational ketamine users. The American Journal of Psychiatry 2005, 162(12):2352-2359.
38. Newcomer J.W., Farber N.B., Jevtovic-Todorovic V., Selke G., Melson A.K., Hershey T., et al. Ketamine-induced NMDA receptor hypofunction as a model of memory impairment and psychosis. Neuropsychopharmacology 1999, 20(2):106-118.
39. Parwani A., Weiler M.A., Blaxton T.A., Warfel D., Hardin M., Frey K., et al. The effects of a subanesthetic dose of ketamine on verbal memory in normal volunteers. Psychopharmacology 2005, 183(3):265-274.
40. Petrakis I.L., Limoncelli D., Gueorguieva R., Jatlow P., Boutros N.N., Trevisan L., et al. Altered NMDA glutamate receptor antagonist response in individuals with a family vulnerability to alcoholism. The American Journal of Psychiatry 2004, 161(10):1776-1782.
41. Rauschecker J.P., Hahn S. Ketamine-xylazine anaesthesia blocks consolidation of ocular dominance changes in kitten visual cortex. Nature 1987, 326(6109):183-185.
42. Rowland L.M., Astur R.S., Jung R.E., Bustillo J.R., Lauriello J., Yeo R.A. Selective cognitive impairments associated with NMDA receptor blockade in humans. Neuropsychopharmacology 2005, 30(3):633-639.
43. Ruff R.M. Ruff figural fluency test: Professional manual 1996, Psychological Assessment Resources, Florida.
44. Shimamura A.P. The role of the prefrontal cortex in dynamic filtering. Psychobiology 2000, 28(2):207-218.
45. Smith R.A. Symbol Digit Modalities Test (SDMT): Manual (revised) 1982, Western Psychological Services, Los Angeles, CA.
46. Sylvester C.Y., Wager T.D., Lacey S.C., Hernandez L., Nichols T.E., Smith E.E., et al. Switching attention and resolving interference: fMRI measures of executive functions. Neuropsychologia 2003, 41(3):357-370.
47. Tong B.S.K., Yip J.T.H., Lee T.M.C., Li L.S.W. Frontal fluency and memory functioning among multiple sclerosis patients in Hong Kong. Brain Injury 2002, 16(11):987-995.
48. Trahan D.E., Larrabee G.J. Continuous Visual Memory Test: Professional manual 1988, Psychological Assessment Resources, Florida.
49. Umbricht D., Schmid L., Koller R., Vollenweider F.X., Hell D., Javitt D.C. Ketamine-induced deficits in auditory and visual context-dependent processing in healthy volunteers: Implications for models of cognitive deficits in schizophrenia. Archives of General Psychiatry 2000, 57(12):1139-1147.
50. Van Petten C., Plante E., Davidson P.S.R., Kuo T.Y., Bajuscak L., Glisky E.L. Memory and executive function in older adults: Relationships with temporal and prefrontal gray matter volumes and white matter hyperintensities. Neuropsychologia 2004, 42(10):1313-1335.
51. Yeung L.Y., Wai M.S.M., Fan M., Mak Y.T., Lam W.P., Li Z., et al. Hyperphosphorylated tau in the brains of mice and monkeys with long-term administration of ketamine. Toxicology Letters 2010, 193(2):189-193.
52. Zuo D.Y., Wu Y.L., Yao W.X., Cao Y., Wu C.F., Tanaka M. Effect of MK-801 and ketamine on hydroxyl radical generation in the posterior cingulate and retrosplenial cortex of free-moving mice, as determined by in vivo microdialysis. Pharmacology, Biochemistry and Behavior 2007, 86(1):1-7.